000 01635 a2200457 4500
005 20250516084532.0
264 0 _c20120912
008 201209s 0 0 eng d
022 _a1873-2518
024 7 _a10.1016/j.vaccine.2012.03.035
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRichert, Laura E
245 0 0 _aA virus-like particle vaccine platform elicits heightened and hastened local lung mucosal antibody production after a single dose.
_h[electronic resource]
260 _bVaccine
_cMay 2012
300 _a3653-65 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aAdministration, Intranasal
650 0 4 _aAnimals
650 0 4 _aAntibodies, Viral
_ximmunology
650 0 4 _aFemale
650 0 4 _aInfluenza Vaccines
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Inbred C57BL
650 0 4 _aNanoparticles
650 0 4 _aOvalbumin
_ximmunology
650 0 4 _aRespiratory Mucosa
_ximmunology
650 0 4 _aTime Factors
650 0 4 _aVaccination
_xmethods
650 0 4 _aVaccines, Conjugate
_xadministration & dosage
700 1 _aServid, Amy E
700 1 _aHarmsen, Ann L
700 1 _aRynda-Apple, Agnieszka
700 1 _aHan, Soo
700 1 _aWiley, James A
700 1 _aDouglas, Trevor
700 1 _aHarmsen, Allen G
773 0 _tVaccine
_gvol. 30
_gno. 24
_gp. 3653-65
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2012.03.035
_zAvailable from publisher's website
999 _c21668411
_d21668411